Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

24065-33-6Rivaroxaban EP Impurity F

● In Stock

Catalogue No.:	VE007629
CAS No.:	24065-33-6
Mol. Formula:	C5H3ClO2S
Mol. Weight:	162.59 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 24065-33-6

Parent drug

Rivaroxaban

IUPAC Name

5-Chlorothiophene-2-carboxylic acid

Pharmacopoeial Synonyms

N/A

Other Synonyms

Rivaroxaban CTCA Impurity; 5-Chloro-2-thiophenecarboxylic acid; 2-Thiophenecarboxylic acid, 5-chloro-; 5-Chloro thiophene-2-carboxylic acid; 5-chloro-2-thiophenecarboxylicacid; 5-Chlorothiophene-2-carboxylicacid; Rivaroxaban metabolite M13; 5-chlorothiophenecarboxylic acid;

Smiles

O=C(C1=CC=C(Cl)S1)O

InChI

InChI=1S/C5H3ClO2S/c6-4-2-1-3(9-4)5(7)8/h1-2H,(H,7,8)

Shipping Condition

Ambient Temperature

Characterization Data (Included)

HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, and Structure Elucidation Report (SER).

Additional Characterization Data

QNMR, D2O Exchange, 13C NMR, 13C APT, COSY NMR, NOESY NMR, 15N NMR, HSQC NMR, HMQC NMR, and HMBC NMR. These are available upon request and may be free or subject to additional charges.

Description

Also known as Rivaroxaban CTCA Impurity or 5-chlorothiophene-2-carboxylic acid, it is an associate degree impurity of Rivaroxaban. Rivaroxaban is utilized to treat deep vein occlusion. a condition within which harmful blood clots kind within the blood vessels of the legs.